SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TRL Total Renal Care

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: wmj who wrote ()3/15/1999 11:59:00 PM
From: Softechie   of 36
 
DLJ Report 3/12/99

TOTAL RENAL CARE HOLDINGS (TRL: $9.0625)+@++ 03/12/99
Preliminary Results of Board Meeting Generally Positive
Earnings Per Share Old New P/E Ratios
(FY:Dec.) 1999E $1.47** $ 6.2
1998A 1.22 7.4
1997A 0.69 13.1

Rating: BUY Change: None 12-Mo. Target: $low $20s

We spoke with TRL management this morning regarding yesterday's board of directors meeting, and we have received some preliminary information. We believe the meeting was generally positive for the company. We anticipate that there will be a building of management infrastructure, focused on the finance and administration levels. The company has already decided to name a new Chief Accounting Officer. We are also expecting TRL to scale back its previous acquisition strategy for the year, setting a target of 4,000 acquired patients in 1999 (our prior expectation was 8,000). The company has conducted a large review of internal controls, including accounts receivable. Recent data has indicated January same-store treatment increases in the 7% range, giving us added comfort in our estimates of $0.34 for 1Q99 and a range of $1.40-$1.50 for this year. Even using the low end of the range, TRL is selling at about 6.5 times this year's EPS estimate. We continue to believe the stock is extremely attractive at current levels and we reiterate our purchase recommendation for investors willing to take some risk for the potential of significant appreciation. While there are several issues surrounding the stock, we believe concerns are more than well reflected in the current stock price. (11:00 AM EST)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext